Meeting
2015 ASCO Annual Meeting
Next-generation sequencing to reveal somatic mutations that confer sensitivity to everolimus.
Authors
Sun Min Lim
Yonsei Cancer Center, Seoul, South Korea
Sun Min Lim , Hyung Soon Park , Sora Kim , Nak-Jung Kwon , Jae-Lyun Lee , Min-Hee Ryu , Jin-Hee Ahn , Jeeyun Lee , Hyo Song Kim , Hyun Ki Kim , Hye Ryun Kim , Hyun Cheol Chung , Joo-Hang Kim , Sang Woo Kim , Yoon-Koo Kang , Byoung Chul Cho
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 33, 2015 (suppl; abstr 11010)
DOI
10.1200/jco.2015.33.15_suppl.11010
Abstract #
11010
Poster Bd #
222
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2017 ASCO Annual Meeting
Pathogenic variants in DNA damage response (DDR) genes in patients with advanced solid tumors.
First Author: Ecaterina Elena Ileana Dumbrava
Poster
2017 Genitourinary Cancers Symposium
Tumor genomic analysis for 128 renal cell carcinoma (RCC) patients receiving first-line everolimus: Correlation between outcome and mutations status in MTOR, TSC1, and TSC2.
First Author: Martin Henner Voss
Poster
2016 ASCO Annual Meeting
Somatic alterations in the PTEN-PI3K-AKT-mTOR pathway in a cohort of 379 ovarian cancer patients.
First Author: Elizabeth Stover